Literature DB >> 26230648

Comorbid Medical Conditions in Vascular Dementia: A Matched Case-Control Study.

Miguel E Habeych1, Ruby Castilla-Puentes.   

Abstract

The objective of the study was to compare the presence of comorbid medical conditions between patients with a vascular dementia (VaD) and a control group, from the Integrated Healthcare Information Services (IHCIS) database. VaD was defined by the International Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-CM) codes 290.40, 290.4, 290.41, 290.42, and, 290.43. An individual matching method was used to select the controls, which were matched to cases on a 15:1 ratio by age, gender, type of health plan, and pharmacy benefits. Alzheimer's disease, any other dementia or cognitive deficits associated were considered exclusion criteria. Among the IHCIS patients 60 years of age or older and full year of eligibility during 2010, there were 898 VaD patients, from which 63.6% were women. Concurrent presence of cerebrovascular disease, atherosclerosis, heart failure, and atrial fibrillation were found at 12.6, 4.6, 2.8, and 1.7 times higher in VaD patients, respectively. Compared to controls, VaD patients had more septicemia, injuries, lung diseases including chronic obstructive pulmonary disease, and urinary diseases (all with df = 897,1; p < 0.0001). The present study confirms that these four medical comorbidities are frequent complications of VaD and physicians should be alert to the presence of them in patients with VaD.

Entities:  

Mesh:

Year:  2015        PMID: 26230648     DOI: 10.1097/NMD.0000000000000336

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN: 0022-3018            Impact factor:   2.254


  3 in total

1.  Serum-borne bioactivity caused by pulmonary multiwalled carbon nanotubes induces neuroinflammation via blood-brain barrier impairment.

Authors:  Mario J Aragon; Lauren Topper; Christina R Tyler; Bethany Sanchez; Katherine Zychowski; Tamara Young; Guy Herbert; Pamela Hall; Aaron Erdely; Tracy Eye; Lindsey Bishop; Samantha A Saunders; Pretal P Muldoon; Andrew K Ottens; Matthew J Campen
Journal:  Proc Natl Acad Sci U S A       Date:  2017-02-21       Impact factor: 11.205

2.  Atrial Fibrillation, Cognitive Decline And Dementia.

Authors:  Alvaro Alonso; Antonio P Arenas de Larriva
Journal:  Eur Cardiol       Date:  2016

3.  Atrial Fibrillation Is Associated with Cognitive Impairment, All-Cause Dementia, Vascular Dementia, and Alzheimer's Disease: a Systematic Review and Meta-Analysis.

Authors:  Christos A Papanastasiou; Christina A Theochari; Nikos Zareifopoulos; Angelos Arfaras-Melainis; George Giannakoulas; Theodoros D Karamitsos; Leonidas Palaiodimos; George Ntaios; Konstantinos I Avgerinos; Dimitrios Kapogiannis; Damianos G Kokkinidis
Journal:  J Gen Intern Med       Date:  2021-07-09       Impact factor: 6.473

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.